Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Sports and Fitness Genomics and Pharmacogenomics Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Sports and Fitness Genomics and Pharmacogenomics Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Sports and Fitness Genomics and Pharmacogenomics Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Sports and Fitness Genomics and Pharmacogenomics Market-Segmentation by Type 5.1 Microarray 5.2 Sequencing 5.3 Polymerase Chain Reaction 5.4 Others 6 Global Sports and Fitness Genomics and Pharmacogenomics Market-Segmentation by Application 6.1 Oncology 6.2 Cardiology 6.3 Neurological Disorders 6.4 Others 7 Global Sports and Fitness Genomics and Pharmacogenomics Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Myriad Genetics 8.1.1 Myriad Genetics Profile 8.1.2 Myriad Genetics Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Myriad Genetics Product/Solution Launches and Enhancements Analysis 8.1.4 Myriad Genetics Business Overview/Recent Development/Acquisitions 8.2 Assurex Health 8.2.1 Assurex Health Profile 8.2.2 Assurex Health Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Assurex Health Product/Solution Launches and Enhancements Analysis 8.2.4 Assurex Health Business Overview/Recent Development/Acquisitions 8.3 GeneDx 8.3.1 GeneDx Profile 8.3.2 GeneDx Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 GeneDx Product/Solution Launches and Enhancements Analysis 8.3.4 GeneDx Business Overview/Recent Development/Acquisitions 8.4 Future Science Group 8.4.1 Future Science Group Profile 8.4.2 Future Science Group Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Future Science Group Product/Solution Launches and Enhancements Analysis 8.4.4 Future Science Group Business Overview/Recent Development/Acquisitions 8.5 GeneTech 8.5.1 GeneTech Profile 8.5.2 GeneTech Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 GeneTech Product/Solution Launches and Enhancements Analysis 8.5.4 GeneTech Business Overview/Recent Development/Acquisitions 8.6 Pathway Genomics 8.6.1 Pathway Genomics Profile 8.6.2 Pathway Genomics Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Pathway Genomics Product/Solution Launches and Enhancements Analysis 8.6.4 Pathway Genomics Business Overview/Recent Development/Acquisitions 8.7 Teva Pharmaceutical Industries 8.7.1 Teva Pharmaceutical Industries Profile 8.7.2 Teva Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Teva Pharmaceutical Industries Product/Solution Launches and Enhancements Analysis 8.7.4 Teva Pharmaceutical Industries Business Overview/Recent Development/Acquisitions 8.8 23andMe 8.8.1 23andMe Profile 8.8.2 23andMe Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 23andMe Product/Solution Launches and Enhancements Analysis 8.8.4 23andMe Business Overview/Recent Development/Acquisitions 9 Global Sports and Fitness Genomics and Pharmacogenomics Market-Segmentation by Geography 10 North America 10.1 North America Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Sports and Fitness Genomics and Pharmacogenomics Production Analysis from 2014-2019E 10.4 North America Sports and Fitness Genomics and Pharmacogenomics Consumption Analysis from 2014-2019E 10.5 North America Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E 10.6 North America Sports and Fitness Genomics and Pharmacogenomics Value, Production and Market Share by Type (2014-2019E) 10.7 North America Sports and Fitness Genomics and Pharmacogenomics Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Sports and Fitness Genomics and Pharmacogenomics by Country (United States, Canada) 10.8.1 North America Sports and Fitness Genomics and Pharmacogenomics Sales by Country (2014-2019E) 10.8.2 North America Sports and Fitness Genomics and Pharmacogenomics Consumption Value by Country (2014-2019E) 10.9 North America Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis 11 Europe 11.1 Europe Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Sports and Fitness Genomics and Pharmacogenomics Production Analysis from 2014-2019E 11.4 Europe Sports and Fitness Genomics and Pharmacogenomics Consumption Analysis from 2014-2019E 11.5 Europe Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E 11.6 Europe Sports and Fitness Genomics and Pharmacogenomics Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Sports and Fitness Genomics and Pharmacogenomics Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Sports and Fitness Genomics and Pharmacogenomics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Sports and Fitness Genomics and Pharmacogenomics Sales by Country (2014-2019E) 11.8.2 Europe Sports and Fitness Genomics and Pharmacogenomics Consumption Value by Country (2014-2019E) 11.9 Europe Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Production Analysis from 2014-2019E 12.4 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E 12.6 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis 13 Latin America 13.1 Latin America Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Sports and Fitness Genomics and Pharmacogenomics Production Analysis from 2014-2019E 13.4 Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption Analysis from 2014-2019E 13.5 Latin America Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E 13.6 Latin America Sports and Fitness Genomics and Pharmacogenomics Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Sports and Fitness Genomics and Pharmacogenomics by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Sports and Fitness Genomics and Pharmacogenomics Sales by Country (2014-2019E) 13.8.2 Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption Value by Country (2014-2019E) 13.9 Latin America Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Production Analysis from 2014-2019E 14.4 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E 14.6 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis 15 Future Forecast of the Global Sports and Fitness Genomics and Pharmacogenomics Market from 2018-2026 15.1 Future Forecast of the Global Sports and Fitness Genomics and Pharmacogenomics Market from 2019-2026 Segment by Region 15.2 Global Sports and Fitness Genomics and Pharmacogenomics Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Sports and Fitness Genomics and Pharmacogenomics Market Value ($) and Growth Rate of Sports and Fitness Genomics and Pharmacogenomics from 2014-2026 Global Sports and Fitness Genomics and Pharmacogenomics Production and Growth Rate Segment by Product Type from 2014-2026F Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Segment by Application from 2014-2019E Figure Sports and Fitness Genomics and Pharmacogenomics Picture Table Product Specifications of Sports and Fitness Genomics and Pharmacogenomics Table Driving Factors for this Market Table Industry News of Sports and Fitness Genomics and Pharmacogenomics Market Figure Value Chain Status of Sports and Fitness Genomics and Pharmacogenomics Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Sports and Fitness Genomics and Pharmacogenomics Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Microarray of Sports and Fitness Genomics and Pharmacogenomics Figure Sequencing of Sports and Fitness Genomics and Pharmacogenomics Figure Polymerase Chain Reaction of Sports and Fitness Genomics and Pharmacogenomics Figure Others of Sports and Fitness Genomics and Pharmacogenomics Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Oncology of Sports and Fitness Genomics and Pharmacogenomics Figure Cardiology of Sports and Fitness Genomics and Pharmacogenomics Figure Neurological Disorders of Sports and Fitness Genomics and Pharmacogenomics Figure Others of Sports and Fitness Genomics and Pharmacogenomics Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Sports and Fitness Genomics and Pharmacogenomics Figure Online Channel of Sports and Fitness Genomics and Pharmacogenomics Table Myriad Genetics Profile (Company Name, Plants Distribution, Sales Region) Figure Myriad Genetics Sales and Growth Rate from 2014-2019E Figure Myriad Genetics Revenue ($) and Global Market Share from 2014-2019E Table Myriad Genetics Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Assurex Health Profile (Company Name, Plants Distribution, Sales Region) Figure Assurex Health Sales and Growth Rate from 2014-2019E Figure Assurex Health Revenue ($) and Global Market Share from 2014-2019E Table Assurex Health Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table GeneDx Profile (Company Name, Plants Distribution, Sales Region) Figure GeneDx Sales and Growth Rate from 2014-2019E Figure GeneDx Revenue ($) and Global Market Share from 2014-2019E Table GeneDx Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Future Science Group Profile (Company Name, Plants Distribution, Sales Region) Figure Future Science Group Sales and Growth Rate from 2014-2019E Figure Future Science Group Revenue ($) and Global Market Share from 2014-2019E Table Future Science Group Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table GeneTech Profile (Company Name, Plants Distribution, Sales Region) Figure GeneTech Sales and Growth Rate from 2014-2019E Figure GeneTech Revenue ($) and Global Market Share from 2014-2019E Table GeneTech Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pathway Genomics Profile (Company Name, Plants Distribution, Sales Region) Figure Pathway Genomics Sales and Growth Rate from 2014-2019E Figure Pathway Genomics Revenue ($) and Global Market Share from 2014-2019E Table Pathway Genomics Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Teva Pharmaceutical Industries Profile (Company Name, Plants Distribution, Sales Region) Figure Teva Pharmaceutical Industries Sales and Growth Rate from 2014-2019E Figure Teva Pharmaceutical Industries Revenue ($) and Global Market Share from 2014-2019E Table Teva Pharmaceutical Industries Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table 23andMe Profile (Company Name, Plants Distribution, Sales Region) Figure 23andMe Sales and Growth Rate from 2014-2019E Figure 23andMe Revenue ($) and Global Market Share from 2014-2019E Table 23andMe Sports and Fitness Genomics and Pharmacogenomics Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Sports and Fitness Genomics and Pharmacogenomics Production Value ($) by Region from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Production Value Share by Region from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Production by Region from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Region from 2014-2019E Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption by Region from 2014-2019E Table North America Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E Table North America Sports and Fitness Genomics and Pharmacogenomics Value ($) by Type (2014-2019E) Table North America Sports and Fitness Genomics and Pharmacogenomics Production by Type (2014-2019E) Table North America Sports and Fitness Genomics and Pharmacogenomics Consumption by Application (2014-2019E) Table North America Sports and Fitness Genomics and Pharmacogenomics Consumption by Country (2014-2019E) Table North America Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Country (2014-2019E) Figure North America Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis Table Europe Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E Table Europe Sports and Fitness Genomics and Pharmacogenomics Value ($) by Type (2014-2019E) Table Europe Sports and Fitness Genomics and Pharmacogenomics Production by Type (2014-2019E) Table Europe Sports and Fitness Genomics and Pharmacogenomics Consumption by Application (2014-2019E) Table Europe Sports and Fitness Genomics and Pharmacogenomics Consumption by Country (2014-2019E) Table Europe Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Country (2014-2019E) Figure Europe Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Value ($) by Type (2014-2019E) Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Production by Type (2014-2019E) Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption by Application (2014-2019E) Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption by Country (2014-2019E) Table Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis Table Latin America Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E Table Latin America Sports and Fitness Genomics and Pharmacogenomics Value ($) by Type (2014-2019E) Table Latin America Sports and Fitness Genomics and Pharmacogenomics Production by Type (2014-2019E) Table Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption by Application (2014-2019E) Table Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption by Country (2014-2019E) Table Latin America Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Country (2014-2019E) Figure Latin America Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Import and Export from 2014-2019E Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Value ($) by Type (2014-2019E) Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Production by Type (2014-2019E) Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption by Application (2014-2019E) Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption by Country (2014-2019E) Table Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Sports and Fitness Genomics and Pharmacogenomics Market PEST Analysis Table Global Sports and Fitness Genomics and Pharmacogenomics Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Sports and Fitness Genomics and Pharmacogenomics Production and Growth Rate Forecast by Region (2019-2026) Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Sports and Fitness Genomics and Pharmacogenomics Production and Growth Rate Forecast by Type (2019-2026) Table Global Sports and Fitness Genomics and Pharmacogenomics Consumption and Growth Rate Forecast by Application (2019-2026)